Jason H. Karnes

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for <i>CYP2C9</i> and <i>HLA‐B</i> Genotypes and Phenytoin Dosing: 2020 Update

Jason H. Karnes, Allan E. Rettie, Andrew A. Somogyi et al. · Clinical Pharmacology & Therapeutics · 2020 · 163 citations · Full text

Toxic Epidermal Necrolysis, Therapeutic Drug Monitoring, Translational Pharmacology +15

Biobanks and Electronic Medical Records: Enabling Cost-Effective Research

Erica Bowton, Julie R. Field, Sunny Wang et al. · Science Translational Medicine · 2014 · 137 citations · Full text

Phenome-wide scanning identifies multiple diseases and disease severity phenotypes associated with HLA variants

Jason H. Karnes, Lisa Bastarache, Christian M. Shaffer et al. · Science Translational Medicine · 2017 · 124 citations · Full text

Mendelian randomisation and experimental medicine approaches to interleukin-6 as a drug target in pulmonary arterial hypertension

Mark Toshner, Colin Church, Lars Harbaum et al. · European Respiratory Journal · 2021 · 83 citations · Full text

Exome Sequencing Implicates an Increased Burden of Rare Potassium Channel Variants in the Risk of Drug-Induced Long QT Interval Syndrome

Peter Weeke, Jonathan D. Mosley, D. Hanna et al. · Journal of the American College of Cardiology · 2014 · 75 citations · Full text

Channelopathies, Genetic Disorder, Exome Sequencing +7